Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 17/20 | 0.60 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.46 |
| ▸ | NEK2 | P51955 | 1/20 | 0.46 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.46 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.46 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.44 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.44 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.44 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2468941 | 0.95 | MET (0.56) | METCHEK1NEK2LIMK1TYRO3 | |
| SCHEMBL2491089 | 0.95 | MET (0.59) | METCHEK1NEK2LIMK1TYRO3 | |
| SCHEMBL2469419 | 0.92 | MET (0.56) | METCHEK1NEK2LIMK1TYRO3 | |
| SCHEMBL2496076 | 0.89 | MET (0.47) | METCHEK1NEK2LIMK1TYRO3 | |
| SCHEMBL2673295 | 0.89 | MET (0.60) | MET | |
| SCHEMBL2497392 | 0.89 | MET (0.56) | METCHEK1NEK2LIMK1TYRO3 | |
| SCHEMBL2468334 | 0.87 | MET (0.63) | MET | |
| SCHEMBL2468835 | 0.87 | MET (0.58) | METCHEK1NEK2LIMK1TYRO3 | |
| SCHEMBL2464380 | 0.87 | MET (0.63) | MET | |
| SCHEMBL1951449 | 0.86 | MET (0.54) | MET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8173653-B2 | Pyridiazinone derivatives for the treatment of tumours | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2012-05-08 | — | — | US | claimed |
| EP-1960370-B1 | PYRIDIAZINONE DERIVATIVES FOR TUMOUR TREATMENT | MERCK PATENT GMBH (DE) | 2011-10-05 | — | — | EP | claimed |